NCT07124754Recruiting
Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer
Development and Validation of a Multimodal Artificial Intelligence Model for Predicting Lymph Node Metastasis in T1 Gastric Cancer and Its Impact on Physician Diagnostic Performance
Source: ClinicalTrials.gov · Last updated 15 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to develop and validate an artificial intelligence (AI) model that integrates clinical, pathological, and imaging data to predict the presence of lymph node metastasis (LNM) in patients with T1-stage gastric cancer. The study will also compare the diagnostic performance of physicians with and without AI assistance, including clinicians with varying levels of experience. The goal is to improve early decision-making and support more personalized treatment strategies for patients with early gastric cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 3 Aug 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 30 Dec 2025
- Lead sponsor
- Qun Zhao
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07124754
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jan 2025 to the primary completion date, 30 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received neoadjuvant chemotherapy or radiotherapy
Other illness
- History of other malignancies within the past 5 years
Other
- Incomplete clinical or pathological data
- Poor quality or missing CT or histopathology images
- Patients with distant metastasis (M1) at diagnosis
- Inability or refusal to provide informed consent
Who the study is looking for
- Age 18 years or older
- Histologically confirmed primary gastric adenocarcinoma
- Clinical stage T1 (T1a or T1b) confirmed by endoscopy and imaging
- Undergoing radical gastrectomy with lymph node dissection
- Preoperative data available: clinical variables, CT imaging, and pathology slides
- Written informed consent provided
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Fourth Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.